Also, with one exception for hormone receptor type [23], these studies have not analysed risks in subdivisions of breast cancer that may have different aetiological characteristics—by menopausal status at the time of breast cancer incidence, by in-situ versus invasive status, and by hormone receptor subtype. The gene discussed is NR4A1; the disease is breast cancer.